Figures
Fig 1 is erroneously duplicated as Fig 5. Please see the correct Fig 5 here.
(A) The APC R1450X reporter cell line was treated for 24 h with 10 μm Escin or 200 μm Ataluren and 50 μm 4EGI-1, 100 μm A-484954 or 5 μm SRI-41315. (B) The APC R1450X reporter cell line (upper blot) and Colo320 cell line (lower blot) were treated for 24 h with 300 μg/ml Erythromycin and 50 μm 4EGI-1, 100 μm A-484954 or 5 μm SRI-41315. APC, adenomatous polyposis coli.
Reference
Citation: Wittenstein A, Caspi M, Rippin I, Elroy-Stein O, Eldar-Finkelman H, Thoms S, et al. (2024) Correction: Nonsense mutation suppression is enhanced by targeting different stages of the protein synthesis process. PLoS Biol 22(2): e3002524. https://doi.org/10.1371/journal.pbio.3002524
Published: February 14, 2024
Copyright: © 2024 Wittenstein et al. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.